Xingnaojing injection
2018YFC1705001-05-02
Approved small_molecule active
Quick answer
Xingnaojing injection for Ischemic Stroke, Acute is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Ischemic Stroke, Acute
- Phase
- Approved
- Modality
- small_molecule
- Status
- active